Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp185 | Benign Thyroid Disorders | ECE2019

Thyroid-related adverse events in patients treated with Nivolumab and Pembrolizumab

Sbardella Emilia , Tenuta Marta , Sirgiovanni Grazia , Pozza Carlotta , Gianfrilli Daniele , Mazzotta Paola , Pandozzi Carla , Cortesi Enrico , Lenzi Andrea , Gelibter Alain J , Isidori Andrea M

Introduction: Immune-Checkpoint Inhibitors (ICI) are frequently associated with thyroid-related adverse events (AE). Several studies analyzed thyroid disfunctions during ICI therapy, but many aspects remain to be characterized, especially for the most recent anti-PD-1 drugs. The aim of this study is to determine incidence and characteristics of PD-1 inhibitors associated thyroid dysfunction.Methods: We retrospectively analyzed data of patients with advan...

ea0063gp196 | Adrenal and Neuroendocrine - Clinical | ECE2019

Sexual function in adrenal insufficiency: data from the DREAM trial

Hasenmajer Valeria , Sbardella Emilia , Pozza Carlotta , Simeoli Chiara , Mazzotta Paola , Lecis Claudio , Lenzi Andrea , Pivonello Rosario , Angelo Jannini Emmanuele , Gianfrilli Daniele , Marcello Isidori Andrea

Introduction: Adrenal Insufficiency (AI) is characterized by absolute or relative deficiency of glucocorticoids and adrenal androgen precursors. Patients with AI show an impaired quality of life, metabolic status, immune function and dysregulated circadian genes. Data on sexual function are scarce and often contradictory. The aims of the present study are to evaluate sexual dysfunction (SD) in women and men patients with AI and to investigate the effects of restoring a more ph...

ea0063gp258 | Thyroid Nodules and Cancer 2 | ECE2019

Predictors of malignancy in thyroid FNA classified as high-risk indeterminate lesions (TIR3B): combining ultrasonographic and cytology features

Cozzolino Alessia , Pozza Carlotta , Faggiano Antongiulio , Pofi Riccardo , Ascoli Valeria , Di Gioia Cira , Bosco Daniela , Lenzi Andrea , Isidori Andrea M , Giannetta Elisa , Gianfrilli Daniele

Introduction: The new Italian cytological classification of thyroid nodules published in 2014 has replaced the TIR3 ‘indeterminate’ category into two subcategory with different risk of thyroid cancer (TC): TIR3A, low-risk indeterminate lesion and TIR3B, high-risk indeterminate lesion. The aim of our study was to describe the incidence of TIR3B in a large prospective cohort of patients, the risk of TC, and its correlation with anamnestic, ultrasonographic (US) and cyt...

ea0063p450 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Prognostic role of angiogenesis-associated factors Tie2 and Angiopoietin 2 in patients with neuroendocrine neoplasms: The NETTARE Unit experience

Puliani Giulia , Sesti Franz , Feola Tiziana , Sbardella Emilia , Cozzolino Alessia , Pofi Riccardo , Faggiano Antongiulio , Lenzi Andrea , Anastasi Emanuela , Venneri Mary A , Giannetta Elisa , Isidori Andrea M

Introduction: The role of Angiopoietin (Ang)/Tie2 kinase pathway in neuroendocrine neoplasms (NENs) has recently received increasing attention, but its clinical role remains unclear. Tie2-receptor inactivation favours chronic inflammation. The balance between its agonist and antagonist regulates its signalling. Aim of this study was to measure serum soluble Tie2 (sTie2) and Ang-2 in patients followed at the NETTARE Unit (NeuroEndocrine TAsk foRcE of ‘Sapienza’ Univer...

ea0063p463 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

InfeCtious disease in patients with Adrenal endocRinOpathies: the ICARO prospective observational study

Minnetti Marianna , Hasenmajer Valeria , Sbardella Emilia , Angelini Francesco , Bonaventura Ilaria , Simeoli Chiara , Chiloiro Sabrina , Pozza Carlotta , Gianfrilli Daniele , De Marinis Laura , Pivonello Rosario , Lenzi Andrea , Isidori Andrea M

Introduction: Cushing’s Syndrome (CS) is associated with an increased frequency and severity of infections. Mild hypercortisolism (MI) from adrenal incidentalomas has been associated with various complications, but data on infections are scarce. Retrospective data on patients with adrenal insufficiency (AI) showed an increased mortality attributed to infections. The approach used was very heterogeneous for all these studies. The aim of the study is to prospectively evalua...

ea0063p1046 | Pituitary and Neuroendocrinology 3 | ECE2019

Recovery of the hypothalamic-pituitary-adrenal and gonadal axes following trans-sphenoidal adenomectomy, a single centre experience

Pofi Riccardo , Gunatilake Sonali , Macgregor Victoria , Cudlip Simon , Joseph Robin , Lenzi Andrea , Tomlinson Jeremy W , Jafar-Mohammadi Bahram , Isidori Andrea M , Pal Aparna

Hypopituitarism is a potential complication of trans-sphenoidal adenomectomy (TSA). Prediction of pituitary function (PF) recovery would inform hormonal replacement strategies. However, the frequency of re-testing of PF is variable across centres. The aim of this study was to determine rates, time and predictors of 6-weeks (6 w) recovery of hypothalamo-pituitary adrenal (HPA) and gonadal function after TSA.Methods: We performed a single-centre, retrospec...

ea0049gp16 | Adrenal 2 | ECE2017

Cardiovascular features of autonomous cortisol secretion in patients with adrenal incidentalomas

Sbardella Emilia , Minnetti Marianna , Rizza Laura , Giorgio Maria Rosaria Di , Hasenmajer Valeria , D'Aluisio Denise , Morelli Sergio , Lenzi Andrea , Isidori Andrea M

Background: Possible Autonomous Cortisol Secretion (pACS) is a condition found in 1–29% of patients with adrenal incidentalomas. The diagnosis of pACS has been variably associated with an increased risk of cardiovascular events and mortality. However, dedicated studies describing the morphologic and functional cardiac alterations in these patients are lacking.Aim: To compare the cardiovascular features of patients with pACS to those with nonfunction...

ea0049ep537 | Diabetes complications | ECE2017

PDE5i preserves renal function in models of Diabetic Nephropathy: from bench to bedside

Pofi Riccardo , Fiore Daniela , Feola Tiziana , Giannetta Elisa , Grazie Giulia Le , Dato Carla Di , Gianfrilli Daniele , Barbano Biagio , Venneri Mary A. , Lenzi Andrea , Isidori Andrea M.

One third of diabetic patients suffer from Diabetic Nephropathy (DN) that leads to end-stage renal disease (ESRD). The molecular pathways involved remain underexplored. We showed that chronic phosphodiesterase-5 inhibition (PDE5i) improve vascular inflammation [1] and tissue remodelling, reducing proteinuria [2] in murine diabetes. Our aim was to investigate the effect of PDE5i on animal and human models of DN.Materials and methods: 16 mice were randomly...

ea0049ep713 | Obesity | ECE2017

Dynapenic obesity and myosteatosis in women with and without the metabolic syndrome

Poggiogalle Eleonora , Donini Lorenzo , Gnessi Lucio , Mariani Stefania , Di Martino Michele , Ciccantelli Barbara , Mancini Cecilia , Arca Marcello , Lenzi Andrea , Lubrano Carla

Introduction: Insulin resistance is a well-known hallmark of the metabolic syndrome (MetS), and it detrimentally affects also protein metabolism, favoring to the decline of lean body mass. The aim of the present study was to explore muscle strength (as a functional consequence of sarcopenic obesity) and muscle quality (namely, myosteatosis) in women with and without the Metabolic Syndrome (MetS).Methods: Study participants were enrolled at the Sapienza U...

ea0059p005 | Adrenal and steroids | SFEBES2018

A model to predict Hypothalamic-Pituitary-Adrenal (HPA) axis recovery at 6 weeks post trans sphenoidal adenomectomy: a single-centre retrospective analysis

Pofi Riccardo , Gunatilake Sonali , Isidori Andrea M , Lenzi Andrea , Macgregor Victoria , Cudlip Simon , Jafar-Mohammadi Bahram , Tomlinson Jeremy W , Pal Aparna

Background: Hypopituitarism can occur post trans-sphenoidal adenomectomy(TSA). Accurate prediction of HPA axis recovery would inform hydrocortisone replacement strategies but there are limited studies on this. In our centre, HPA axis is assessed with pre-operative short synacthen test (SST), day-8 post TSA 9am cortisol and 6-week post-TSA SST. Patients are commenced on hydrocortisone post TSA until 6 weeks review.Methods: We performed a single-centre, lo...